Real figures from the London 2026 post-show report: who attended, the meetings sponsors held and what they said.
ImmunoMark Summit London 2026, the launch edition of the series, ran on 5–6 March 2026 at the DoubleTree by Hilton London Tower of London. It had two parallel streams, Next-Gen Immuno-Oncology and Biomarkers & Companion Diagnostics, and a meeting programme built around pre-scheduled 20-minute 1:1s between sponsors and delegates.
Every figure on this page comes from the London 2026 post-show report.
| Measure | Figure | Basis |
|---|---|---|
| Meetings conducted across the event | 200+ | Post-show report |
| Meetings per sponsor | 15–25 | Post-show report |
| Pre-scheduled 1:1s delivered for title sponsors | 55+ | Post-show report |
| Senior decision-makers in the audience | 70% | Post-show report |
Sponsors came from biomarker and histology lab services, preclinical and immunology CROs, cell analysis, cell culture and epigenomics tools, spatial biology, proteomics and research data. In other words, the companies that sell to oncology R&D teams.
Quotes collected from sponsors at the event, shown with the job title and type of company only.
“My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.”
Senior Business Development Director, Europe, immunology services CRO
“The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.”
Biopharma Business Development Manager, EMEA, epigenomics solutions company
“Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.”
Research Account Manager, cell separation and analysis company
“We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.”
Project Manager, cell culture products company
“Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.”
Business Development Executive, histology services laboratory
“We got the occasion to discuss customer projects and understand their needs better and how we can help them.”
Epigenomics Applications Specialist, epigenomics solutions company
“The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.”
Product Specialist, spatial proteomics company
“We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.”
BD Manager, Europe, European life science company
The 2027 series runs the same meeting model in three cities: San Diego (10–11 February 2027, launch edition, 300+ attendees), London (3–4 March 2027, 2nd annual, 400+ target) and Boston (June 2027, launch edition, 300+ attendees).
Want to see what 15–25 meetings could be worth to your team? Put your own deal value and close rate into the calculator.
Open the ROI calculatorTell us which roles you need to meet and we will send the prospectus and current availability for San Diego, London and Boston 2027.